REX American Resources Corporation
NYSE:REXChemicals - Specialty
-$0.13 today
- Market cap
- $1.17B
- Beta
- 0.61
- P/E (TTM)
- 15.4
- EPS (TTM)
- $2.80
Volume 0.30M
Average 0.21M
REX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
REX American Resources CorporationNYSE: REX
EBITDA · Q1 FY2026 · quarter ended Apr 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $31.07M rose 66.7% year over year, ahead of the +6.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 9.8% from the prior quarter. Over 3 fiscal years it compounded at +14.2% a year.
Context
- EBITDA amounted to 16.2% of revenue in FY2025, down 1.6 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $94.3M (-10.5%) for the fiscal year ending Jan 2027, a slowdown from the -8.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $31.07M+9.8% QoQ
- Last fiscal yearJan 2026
- $105.34M-8.1% YoY
- LTMApr 2026
- $118.71M+6.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +66.7% | +43.4% | -23.2 pp |
| 1 year | -8.1% | -10.5% | -2.4 pp |
| 3-year CAGR | +14.2% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 105.34M USD
- Year-over-year change
- -8.1%
- 4-year CAGR
- +1.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 105.34M | -8.1% |
| FY2024 | 2025-01-31 | 114.59M | -5.7% |
| FY2023 | 2024-01-31 | 121.52M | +71.7% |
| FY2022 | 2023-01-31 | 70.78M | -28.8% |
| FY2021 | 2022-01-31 | 99.43M | — |
EBITDA vs competitors
How REX compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +6.6% is the 7th highest of 11, against a peer median of +30.1%.
- EBITDA amounts to 18.1% of revenue for REX, versus a peer median of 18.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$6.93B BRL | +2564.8% | -57.3% | 10.4% | |
| LTM Mar 2026 | $235.69M USD | +22.6% | -19.4% | 36.6% | |
| LTM Mar 2026 | $151.69M USD | +37.7% | -13.1% | 18.5% | |
| LTM Mar 2026 | $143.17M USD | +374.2% | +5.5% | 7.4% | |
| LTM Mar 2026 | $139.93M USD | -27.5% | -10.3% | 6.0% | |
| LTM Apr 2026 | $118.71M USD | +6.6% | +14.2% | 18.1% | |
| LTM Apr 2026 | $88.81M USD | +1.7% | +64.4% | 18.1% | |
| LTM Mar 2026 | -$23.99M USD | +67.2% | — | — | |
| LTM Mar 2026 | -CA$38.33M CAD | +44.6% | — | — | |
CNLCollective Mining Ltd. | LTM Mar 2026 | -$43.45M USD | -12.6% | — | — |
| LTM Jun 2025 | -$47.47M USD | -1460.7% | — | 8466.9% | |
| Peer median (excluding REX) | — | +30.1% | -11.7% | 18.1% | |
Competitors are the stored peer set for REX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Jan 2024 | FY2024 Jan 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 774.8M | 855M | 833.38M | 642.49M | 650.49M |
| Cost of Revenue | 677.24M | 806.4M | 735.17M | 551.01M | 556.78M |
| Gross Profit | 97.56M | 48.6M | 98.22M | 91.48M | 93.71M |
| Gross Margin | 12.6% | 5.7% | 11.8% | 14.2% | 14.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 28.48M | 22.83M | 29.38M | 27.15M | 32.62M |
| Operating Expenses | 28.48M | 22.83M | 29.38M | 27.15M | 32.62M |
| Depreciation & Amortization | 23.59M | 23.3M | 23.04M | 21.72M | 16.76M |
| EBITDA | 99.43M | 70.78M | 121.52M | 114.59M | 105.34M |
| EBITDA Margin | 12.8% | 8.3% | 14.6% | 17.8% | 16.2% |
| Operating Income | 69.08M | 25.78M | 68.84M | 64.33M | 61.09M |
| Operating Margin | 8.9% | 3.0% | 8.3% | 10.0% | 9.4% |
| Interest Income | 130K | 12.96M | 15.72M | 19.16M | 15M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 6.75M | 21.7M | 29.65M | 28.54M | 27.48M |
| Income Before Tax | 75.84M | 47.48M | 98.48M | 92.87M | 88.57M |
| Pre-Tax Margin | 9.8% | 5.6% | 11.8% | 14.5% | 13.6% |
| Income Tax Expense | 19.03M | 9.54M | 22.56M | 21.39M | (6.5M) |
| Net Income | 52.36M | 27.7M | 60.94M | 58.17M | 82.95M |
| Net Margin | 6.8% | 3.2% | 7.3% | 9.1% | 12.8% |
| EPS (Basic) | 1.46 | 0.79 | 1.75 | 1.65 | 2.50 |
| EPS (Diluted) | 1.46 | 0.79 | 1.74 | 1.65 | 2.50 |
| Weighted Avg Shares | 35.89M | 35.28M | 34.96M | 35.27M | 33.21M |
| Weighted Avg Shares (Diluted) | 35.89M | 35.28M | 35.15M | 35.27M | 33.21M |
REX American Resources Corporation
NYSE:REX
Intrinsic Alpha fair value
Locked
Current Price
$35.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.